MPWT
GCVRZ

MassMutual Private Wealth & Trust’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-44
Closed -$16 – 1013
2017
Q3 		$16 Hold
44
– – ﹤0.01% 1047
2017
Q2 		$17 Hold
44
– – ﹤0.01% 1021
2017
Q1 		$20 Hold
44
– – ﹤0.01% 1005
2016
Q4 		$17 Buy
+44
New +$15 ﹤0.01% 676
2016
Q2 		$11 Hold
44
– – ﹤0.01% 814
2016
Q1 		$5 Buy
44
+30
+214% +$3 ﹤0.01% 806
2015
Q4 		$2 Hold
14
– – ﹤0.01% 814
2015
Q3 		$7 Hold
14
– – ﹤0.01% 831
2015
Q2 		$7 Hold
14
– – ﹤0.01% 731
2015
Q1 		$9 Hold
14
– – ﹤0.01% 723
2014
Q4 		$11 Hold
14
– – ﹤0.01% 594
2014
Q3 		$7 Hold
14
– – ﹤0.01% 790
2014
Q2 		$7 Hold
14
– – ﹤0.01% 538
2014
Q1 		$4 Hold
14
– – ﹤0.01% 592
2013
Q4 		$5 Buy
+14
New +$17 ﹤0.01% 483

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

MassMutual Private Wealth & Trust's GCVRZ Position: Q4 2017 in Review

MassMutual Private Wealth & Trust sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2017, closing a stake of 44 shares — an estimated $16 sold.

MassMutual Private Wealth & Trust first reported a position in GCVRZ in Q4 2013 and held it in 15 quarters. The position peaked at $20 in Q1 2017. 105 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2017.

  • MassMutual Private Wealth & Trust reported no remaining Sanofi Contingent Value Rights position as of Q4 2017 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 44 Sanofi Contingent Value Rights shares in Q4 2017, an estimated $16.
  • MassMutual Private Wealth & Trust first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 15 quarters.
  • MassMutual Private Wealth & Trust's Sanofi Contingent Value Rights position peaked at $20 in Q1 2017.
  • 105 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2017.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2017, filed 21 Feb 2018.